AMY DE LA ROSA, PA-C
Physician Assistant in BEDFORD, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
AMY DE LA ROSA, PA-C filed 391 Medicare Part D claims in 2023 as a Physician Assistant in BEDFORD, Texas, prescribing 72% generic.
- 391
- Part D claims, 2023
- 72%
- generic prescribing
- $1.9K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
AMY DE LA ROSA, PA-C's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
391 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about AMY DE LA ROSA, PA-C?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Physician Assistant compares to other specialties among Texas providers
Physician Assistant share within Texas
Physician Assistant is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Physician Assistant (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Physician Assistant ABMS/AOA estimate
Est. board-certified rate (Physician Assistant) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Physician Assistant US NPIs
Specialty board-certified rate — Physician Assistant estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
AMY DE LA ROSA, PA-C appears in the CMS NPPES registry as a Physician Assistant provider holding PA-C credentials at 1600 CENTRAL DR STE 155, BEDFORD, TX, 76022, with a listed phone of (817) 267-8470. NPI 1972730513 was issued on 06/22/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DE LA ROSA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 391 prescription claims written by this provider, covering 216 Medicare beneficiaries and totaling roughly $52K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1972730513 |
|---|---|
| Specialty | Physician Assistant |
| Credentials | PA-C |
| Gender | Female |
| NPI Issued | 06/22/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm AMY DE LA ROSA, PA-C's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where AMY DE LA ROSA, PA-C bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMY DE LA ROSA, PA-C. Source: openpaymentsdata.cms.gov.
Total received
$1.9K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to AMY DE LA ROSA, PA-C. To verify AMY DE LA ROSA, PA-C's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
28% brand-name claims vs 72% generic, on 391 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 742
- Total Day Supply
- 18,659
- Brand vs Generic
- 28% brand / 72% generic
- Brand Drug Cost
- $40K
- Generic Drug Cost
- $12K
- Antibiotic Claims
- 12
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.63
- Gender Split
- 75% female / 25% male
- Age Distribution
- <65: 17, 65-74: 103, 75-84: 81, 85+: 15
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What AMY DE LA ROSA, PA-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pantoprazole Sodium
Pantoprazole Sodium
69 claims
- Omeprazole
Omeprazole
65 claims
- Sutab
Sutab
43 claims
- Dicyclomine Hcl 26
Dicyclomine Hcl
26 claims
- Clenpiq 19
Clenpiq
19 claims
- Famotidine 19
Famotidine
19 claims
- Sucralfate 17
Sucralfate
17 claims
- Hydrocortisone 14
Hydrocortisone
14 claims
| Drug | Claims |
|---|---|
| Pantoprazole Sodium | 69 |
| Omeprazole | 65 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 43 |
| Dicyclomine Hcl | 26 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 19 |
| Famotidine | 19 |
| Sucralfate | 17 |
| Hydrocortisone | 14 |
| Ondansetron Odt Ondansetron | 13 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physician Assistant Overview
How AMY DE LA ROSA, PA-C fits within the Physician Assistant landscape nationally.
AMY DE LA ROSA, PA-C's 391 claims are below the specialty average of 790.
Nearby Physician Assistant Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as DE LA ROSA.
Compare Physician Assistant nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is AMY DE LA ROSA, PA-C's specialty? ▼
How much does AMY DE LA ROSA, PA-C prescribe under Medicare Part D? ▼
Where is AMY DE LA ROSA, PA-C located? ▼
What is AMY DE LA ROSA, PA-C's NPI number? ▼
Does AMY DE LA ROSA, PA-C prescribe more brand-name or generic drugs? ▼
How many Physician Assistant providers are there in the US? ▼
What drugs does AMY DE LA ROSA, PA-C prescribe most often? ▼
Does AMY DE LA ROSA, PA-C accept Medicare? ▼
How can I verify AMY DE LA ROSA, PA-C's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology